Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
7,420.00    35.00 (0.47%)
Bid:
7,425.00
Ask:
7,430.00
Spread: 5.00 (0.067%)
Market Cap: £32.85b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

SID Appointment and Board Committee Changes

10 Apr 2026 11:00

RNS Number : 0137A
Coca-Cola Europacific Partners plc
10 April 2026
 

SENIOR INDEPENDENT DIRECTOR APPOINTMENT AND

CHANGES IN COMPOSITION OF THE BOARD COMMITTEES

 

The Board of Directors of Coca-Cola Europacific Partners plc (CCEP) announces the following changes to the composition of the Board Committees with effect from the conclusion of the Annual General Meeting (AGM) to be held on 28 May 2026:

 

· Mary Harris, Independent Non-executive Director, will be appointed Senior Independent Director;

 

· Nathalie Gaveau, Independent Non-executive Director, will retire as a member of the Environmental, Social and Governance Committee;

 

· Dessi Temperley, Independent Non-executive Director, will be appointed as a member of the Environmental, Social and Governance Committee;

 

· Nicolas Mirzayantz, Independent Non-executive Director, will be appointed as a member of the Nomination Committee and will retire as a member of the Audit Committee;

 

· Mark Price, Independent Non-executive Director, will be appointed as Chairman of the Affiliated Transaction Committee; and

 

· subject to their formal appointment as Independent Non-executive Directors at the AGM:

 

Laurence Debroux and Uvashni Raman will be appointed as members of the Audit Committee;

Laurence Debroux will be appointed as a member of the Remuneration Committee; and

Uvashni Raman will be appointed as a member of the Affiliated Transaction Committee.

 

Following the changes noted above, the membership of the Committees will be as follows:

 

Audit Committee

Affiliated Transaction Committee

Environmental, Social and Governance Committee

Dessi Temperley (Chairman)

Mark Price (Chairman)

Mario Rotllant (Chairman)

Robert Appleby

Sol Daurella

Robert Appleby

John Bryant

Nathalie Gaveau

Nicolas Mirzayantz

Laurence Debroux

Alfonso Líbano Daurella

Dessi Temperley

Uvashni Raman

Uvashni Raman

Nancy Quan

   

Nomination Committee

Remuneration Committee

Mary Harris (Chairman)

John Bryant (Chairman)

Manolo Arroyo

Manolo Arroyo

Sol Daurella

José Ignacio Comenge

Nicolas Mirzayantz

Laurence Debroux

Mark Price

Mary Harris

 

This notification is made in accordance with UK Listing Rule 6.4.6R(3).

 

CONTACTS

 

Company Secretariat

Svetlana Walker

svetlana.walker@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANLEFENKEEA
Date   Source Headline
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
17th Mar 20233:30 pmRNSBlock listing Interim Review
17th Mar 202311:55 amRNSAnnual Financial Report
14th Mar 20239:45 amRNSDirector/PDMR Shareholding
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20233:50 pmRNSDirector/PDMR Shareholding
1st Mar 20233:20 pmRNSTotal Voting Rights
23rd Feb 202310:30 amRNSDirector/PDMR Shareholding
16th Feb 20237:00 amRNSPreliminary Unaudited Results Q4 & FY 2022
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202310:00 amRNSDirectorate Change
1st Feb 20233:30 pmRNSTotal Voting Rights
23rd Jan 20234:30 pmRNSDirector/PDMR Shareholding
16th Jan 20232:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20232:40 pmRNSTotal Voting Rights
21st Dec 20223:45 pmRNSDirector/PDMR Shareholding
1st Dec 20223:15 pmRNSTotal Voting Rights
23rd Nov 20228:00 amRNSDirector/PDMR Shareholding
15th Nov 20225:30 pmRNSDirector/PDMR Shareholding
4th Nov 20225:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3, Investor Event & Interim Dividend Declaration
1st Nov 20223:45 pmRNSTotal Voting Rights
21st Oct 20223:00 pmRNSDirector/PDMR Shareholding
14th Oct 20222:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
22nd Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 202210:00 amRNSBlock listing Interim Review
16th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20224:45 pmRNSDirector/PDMR Shareholding
1st Sep 20223:00 pmRNSTotal Voting Rights
22nd Aug 20224:00 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSResults for the six months ended 1 July 2022
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
1st Aug 20223:45 pmRNSTotal Voting Rights
20th Jul 20224:30 pmRNSDirector/PDMR Shareholding
14th Jul 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:30 pmRNSDirector/PDMR Shareholding
9th Jun 202212:00 pmRNSDirector/PDMR Shareholding
1st Jun 20223:10 pmRNSTotal Voting Rights
27th May 20223:30 pmRNSResult of AGM
24th May 20223:30 pmRNSDirector/PDMR Shareholding
16th May 202212:00 pmRNSLetter to Shareholders
3rd May 20222:40 pmRNSTotal Voting Rights
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSQ1 2022 Trading Update
21st Apr 20225:20 pmRNSDirector/PDMR Shareholding
14th Apr 20229:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.